IRCT201202241556N34已完成2 期
Minocycline as adjuvant therapy on negative symptoms in patients with chronic schizophrenia that are receiving resperidon: a double blind and placebo controlled randomized clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: Age between 18-50; Diagnosis of Schizophrenia based on DSM IV; chronic Schizophrenia( duration of the disorder>2 years); Stable on antipsychotics
排除标准
- •Substance dependence; IQ <70; any other mental disorder on axis I; Any serious medical or neurological problem ; receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month; receiving ECT during the last 14 days; hepatic disease
研究者
相似试验
招募中
2 期
Minocycline for the treatment of the acute phase of maniaBipolar disorder.Bipolar disorderIRCT20090117001556N155Tehran University of Medical Sciences50
尚未招募
不适用
Minocycline as an adjunctive therapy in patients with bipolar maniaCTRI/2021/12/038752Central Institute of Psychiatry
已完成
2 期
Minocycline as a new treatment for depressioACTRN12612000283875Mental Health Research Institute80
已完成
3 期
Minocycline in the treatment of DepressioMajor depressive disorder.Major Depressive episodeIRCT201405271556N57Tehran University of Medical Sciences50
进行中（未招募）
1 期
The Benefit of Minocycline on Negative Symptoms in Psychosis: Extent and Mechanisms - The Benefit of Minocycline on Negative Symptoms in Psychosis (BeneMin)schizophreniaEUCTR2010-022463-35-GBManchester Mental Health and Social Care Trust170